Life sciences investor Catalio Capital Management has boosted its 2022 fundraising with the final close of its inaugural special situations fund. The post Biomed investor Catalio Capital boosts 2022 fundraising with debut credit opportunities fund close
Advent International has merged its portfolio business Caldic with Wilbur-Ellis' Connell to create a life science and chemicals company with combined revenues of about €3bn. The post Advent creates €3bn revenue chemicals company by merging
European private equity house Andera Partners has raised €456m for its biggest-ever life sciences fund. The post Andera Partners raises €456m for its biggest-ever life sciences fund first appeared on AltAssets Private Equity News.
University of Oxford-partnering investment firm Oxford Science Enterprises has raised £250m to drive the creation and growth of businesses built on ground-breaking science from the hallowed institution. The post Oxford University investment partner OSE raises
European life science venture capital firm Forbion has held a first close of a €470m fund to invest in late-stage European life science companies. The post Forbion holds €470m first close for Growth Opp Fund
Newly-found B2B life science investor Biospring Partners has closed its debut fund and co-investment vehicles with north of $245m in capital commitments. The post New B2B life science investor Biospring Partners brings in $245m for
Cathay Capital has launched a new €500m health fund to invest in healthcare, life sciences and technology. The post Cathay Capital launches €500m health fund for tech-enabled healthcare, life science investments first appeared on AltAssets
NovaQuest Capital Management has struck a $500m hard cap close for its latest private equity investment fund. The post NovaQuest strikes $500m hard cap for latest life science, pharma services-focused private equity fund first appeared
Cambridge Innovation Capital, the venture capital investor founded to improve the success rate of deeptech and life sciences businesses originating from the University of Cambridge, has raised £225m for its second fund. The post Cambridge
Biopharma, medical tech and life sciences-focused 5AM Ventures has raised $750m across a new pair of funds targeting startups across the early and late-stage of investment. The post 5AM Ventures ups fundraising ante with $750m
Life sciences investor Pappas Capital is in the market for up to $250m of new capital through its Fund VI raise - double the total it hoped to gather for its previous fund. The post
Blackstone Growth has led a $200m financing round in cloud-based biomedical data analysis software DNAnexus. The post Blackstone Growth leads financing round in biomedical data analysis software DNAnexus first appeared on AltAssets Private Equity News.
Global buyout giant Carlyle has sold life science industry equipment and supplies provider Thomas Scientific to Broad Sky Partners. The post Carlyle sells Thomas Scientific to Broad Sky Partners after successful bolt-on push, market expansion
Institutional investment major Caisse de dépôt et placement du Québec has picked up a significant minority interest in QIMA, a provider of supply chain compliance solutions. The post CDPQ takes stake in supply chain testing,
Bioscience and life sciences investor NovaQuest Capital Management has bought TechAccel's stake in Covenant Animal Health Partners. The post NovaQuest Capital picks up TechAccel stake in Covenant Animal Health Partners first appeared on AltAssets Private
Global buyout major Advent International has agreed to acquire €1bn-generating life sciences and specialty chemical producer Caldic BV from Goldman Sachs AM. Caldic will be merged with Advent portfolio company Latin American chemical distributor Grupo
Buyout giant EQT has agreed to buy into €2.2bn-managing European life science venture capital firm LSP for €450m to strengthen its position in the healthcare sector. A potential earn-out payment of €25m will also be
Bain Capital has made a $300m investment in Polaris-backed Cardurion Pharmaceuticals through Bain Capital Life Sciences and Bain Capital Private Equity. The post Bain Capital joins Polaris to back cardiovascular treatment developer Cardurion in $300m
Sverica Capital Management has bought into system integration firm Control Concepts. The post $1.1bn-managing Sverica buys into system integration firm Control Concepts first appeared on AltAssets Private Equity News.
Healthcare-focused buyout house ArchiMed has bought into Belgium-based Xpress Biologics to finance a 10x expansion of its production capacity, the firm said. The post ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer
